Sep 13, 2013 by Dan CarrollCan This Biotech Star Deliver for Dividend Investors?Biotech isn't known for income investing, but one industry star has what it takes to compete for dividend investors' dollars.
Sep 13, 2013 by Dan CarrollWill Abbott and Johnson & Johnson Make a Deal?As J&J contemplates letting go of its ortho diagnostics business, Abbott makes sense to snap up this sale.
Sep 13, 2013 by Dan CarrollWhy This Stock Has Missed the Mark in 2013Sanofi's one of the health care sector's biggest names, but it hasn't lived up to expectations this year.
Sep 12, 2013 by Dan CarrollDisney's Bounce Bails Out the DowThe blue-chip index is flat following a huge spike in Disney shares this afternoon.
Sep 11, 2013 by Dan CarrollIBM Leads the Dow's Strong Weekly SurgeDisney also hits the mark on a day full of green on the markets
Sep 10, 2013 by Dan CarrollSweeping Changes Hit the Dow on a Day of Triple-Digit GainsOut go Alcoa, HP, and Bank of America in a giant switch-up for the index.
Sep 9, 2013 by Dan CarrollCaterpillar Powers the Dow's Big RallyManufacturing stocks get a big boost courtesy of China's trade gains.
Sep 9, 2013 by Dan Carroll"Riddick" Rises to No. 1 in Weekend Box Office SalesSci-fi thriller "Elysium" ranks second worldwide over the weekend thanks to strong international revevenue
Sep 7, 2013 by Dan CarrollThe Run Isn't Over for This Booming BiotechNPS Pharmaceuticals has soared in 2013, but is there still time for you to reap this stock's rewards?
Sep 6, 2013 by Dan CarrollWill Taxes Slow Down Japan's Rally?Japan's sales tax might hurt investors in the short run, but economists point out a need to get a handle on the country's burgeoning debt
Sep 6, 2013 by Dan CarrollWill China's Corporate Crackdown Scare Off Investors?The Hang Seng scored a big week, but this emerging-market star still faces tough hurdles
Sep 6, 2013 by Dan CarrollGermany's Trade Falters as the DAX Eases HigherCan Europe's top economy continue holding up the lagging euro zone?
Sep 6, 2013 by Dan CarrollCaterpillar Picks Up Steam as the Dow Ends the Week in the GreenThe index beats out downbeat reporting from the U.S. labor market.
Sep 6, 2013 by Dan CarrollCan This Troubled Pharma Giant Bounce Back?Eli Lilly's facing a tough future of patent expirations, but is there upside to this pharmaceutical stock?
Sep 6, 2013 by Dan CarrollIs There Hope for This Top Dividend?AstraZeneca's future has taken a beating, but is its high-yielding dividend in danger?
Sep 5, 2013 by Dan CarrollTelecoms Hold Back the DowJPMorgan picks up steam to rank among the Dow's leaders.
Sep 4, 2013 by Dan CarrollTech's Bounce Pulls the Dow to Triple-Digit GainsIntel leads a resurgent index higher after beginning shipments of a new line of chips.
Aug 31, 2013 by Dan CarrollThe 3 Most Profitable Medical Device CompaniesWhich device makers are bring home the biggest rewards?
Aug 30, 2013 by Dan CarrollMicrosoft Falls as the Dow Loses GroundJohnson & Johnson also takes a tumble in a day when markets fall into the red
Aug 30, 2013 by Dan CarrollSt. Jude's Enlightening New HopeThis company's struggling with declining sales, but renal denervation offers a long-term hope for St. Jude's future.
